Why Are HCA Healthcare Shares Trading Lower Today

  • HCA Healthcare Inc HCA has posted Q1 FY22 revenues of $14.94 billion, compared to $13.98 billion a year ago and beating the consensus of $14.74 billion.
  • EPS of $4.12, higher than the $4.14 reported in 1Q of 2021, missed the estimate of $4.25.
  • Same facility admissions increased 2.1% Y/Y, and same facility equivalent admissions increased 5%.
  • Same facility revenue per equivalent admission increased 2.7%.
  • Adjusted EBITDA totaled $2.94 billion, compared to $3.05 billion in Q1 FY21.
  • Dividend: HCA Healthcare declared a quarterly cash dividend of $0.56 per share, payable on June 30, at the record date of June 16.
  • FY 22 Guidance: HCA Healthcare has lowered FY22 sales guidance to $59.5 billion - $61.5 billion, from $60 billion - $62 billion, compared to the consensus of $61.2 billion.
  • It expects an adjusted EBITDA of $11.8 billion - $12.4 billion down from $12.55 billion - $13.05 billion expected earlier.
  • HCA sees EPS of 16.40 - $17.60, lower than the prior guidance of $18.40 - $19.20 and against the consensus of $18.93.
  • The guidance includes the company's current expectations regarding the impact of the COVID-19 pandemic and related government legislation, labor cost, and inflation.
  • Price Action: HCA shares are down 10.2% at $242.00 during the premarket session on the last check Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceDividendsHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!